Vendor profile
Celltrion Healthcare Netherlands B.V.
NL- Awards
- 19
- Total awarded value
- €67,192,216
- Countries
- Belgium
- Latest award
- Jul 7, 2026
- Expiring within 12 months
- 2
Award history
| Date | Buyer | Title | Category | Value | Country | Expires | Source |
|---|---|---|---|---|---|---|---|
| 07/07/2026 | Cliniques universitaires Saint Luc | Belgium – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – Bévacizumab | Pharmaceuticals | €503.4K | BE | — | View on TED ↗ |
| 07/01/2026 | UZ Leuven | Belgium – Pharmaceutical products – Leveren van een terugbetaalde vorm van Bevacizumab 100 mg/4 ml en 400 mg/ 16ml voor intraveneus gebruik | Pharmaceuticals | €2.9M | BE | 11/09/2027 | View on TED ↗ |
| 06/18/2026 | AZ Delta vzw | Belgium – Pharmaceutical products – Tocilizumab IV | — | €385.4K | BE | 06/14/2030 | View on TED ↗ |
| 04/29/2026 | VITAZ vzw | Belgium – Various medicinal products – Denosumab | — | €1.0M | BE | 03/31/2030 | View on TED ↗ |
| 04/07/2026 | AZ Delta vzw | Belgium – Pharmaceutical products – Parenterale cytostatica | — | €4.0M | BE | 04/19/2030 | View on TED ↗ |
| 11/12/2025 | UZ Leuven | Belgium – Pharmaceutical products – Leveren van Trastuzumab en Rituximab voor intraveneus gebruik | — | €4.3M | BE | — | View on TED ↗ |
| 05/19/2025 | VZW Maria Middelares | Belgium – Various medicinal products – Raamovereenkomst voor de aankoop en levering van Infliximab IV | — | €22.1M | BE | 05/11/2027 | View on TED ↗ |
| 04/14/2025 | Universitair Ziekenhuis Gent | Belgium – Pharmaceutical products – Raamovereenkomst voor het leveren van rituximab en trastuzumab | — | €8.6M | BE | 02/18/2029 | View on TED ↗ |
| 03/06/2025 | Cliniques universitaires Saint Luc | Belgium – Medical equipments, pharmaceuticals and personal care products – Rituximab et Trastuzumab | — | €1.6M | BE | — | View on TED ↗ |
| 01/14/2025 | Vivalia | Belgium – Pharmaceutical products – Accord-cadre relatif à la fourniture de TRASTUZUMAB et RITUXIMAB IV pour les besoins des pharmacies de Vivalia, agissant en Centrale d’achats | — | — | BE | — | View on TED ↗ |
| 09/10/2024 | AZ Delta vzw | Belgium – Pharmaceutical products – Trastuzumab - Rituximab IV | — | €187.2K | BE | 04/19/2026 | View on TED ↗ |
| 08/26/2024 | VZW Maria Middelares | Belgium – Antineoplastic agents – Raamovereenkomst voor het aankopen en leveren van Trastuzumab en Rituximab | — | €13.7M | BE | 09/01/2026 | View on TED ↗ |
| 08/14/2024 | Vivalia | Belgium – Pharmaceutical products – Accord-cadre relatif à la fourniture d’INFLIXIMAB pour injection intravitréenne pour les besoins des pharmacies de Vivalia, agissant en Centrale d’achats | — | — | BE | — | View on TED ↗ |
| 05/28/2024 | VITAZ vzw | Belgium – Various medicinal products – Monoklonale antilichamen - Trastuzumab 2024 | — | €2.4M | BE | 07/26/2028 | View on TED ↗ |
| 05/28/2024 | VITAZ vzw | Belgium – Various medicinal products – Monoklonale antilichamen - Rituximab 2024 | — | €1.2M | BE | 07/26/2028 | View on TED ↗ |
| 05/21/2024 | AZ Sint-Lucas Brugge vzw | Belgium – Various medicinal products – Raamovereenkomst voor de levering van Rituximab IV en Trastuzumab IV | — | €59.1K | BE | — | View on TED ↗ |
| 04/29/2024 | AZ Sint-Jan Brugge AV | Belgium – Pharmaceutical articles – Raamovereenkomst voor leveren van Cytostatica geneesmiddelen | — | €3.4M | BE | 10/14/2025 | View on TED ↗ |
| 04/17/2024 | AZ Maria Middelares | Belgium – Various medicinal products – Raamovereenkomst voor de aankoop en levering van Bevacizumab | — | €920.1K | BE | — | View on TED ↗ |
| 03/05/2024 | MercurHosp ASBL | Belgium – Pharmaceutical products – Fourniture de Trastuzumab IV | — | — | BE | — | View on TED ↗ |